All resources
Insights 30 June 2026 7 min read

AI assurance in healthcare: what good actually looks like

Beyond the model card. A practical view of what assured clinical AI looks like in 2026, and how to evidence it.

AI assurance in healthcare has matured fast. The conversation has moved on from 'is your model accurate?' to 'can you evidence safe behaviour in real clinical use, over time, across populations?'. Here's what good now looks like.

The six pillars of clinical AI assurance

  • Intended use clearly defined, who, what for, with what guardrails
  • Training and evaluation data lineage, provenance, consent, representativeness
  • Pre-deployment evaluation, clinical performance, bias, edge cases
  • Human-in-the-loop design, where the clinician decides, where the model assists
  • Post-market monitoring, drift, fairness, real-world performance
  • Incident and change management, what happens when the model is updated

Where most products fall short

Pre-deployment evaluation is usually fine. Post-market monitoring is where most products are weak, performance over time, across patient groups and across new sites is rarely instrumented from day one. NHS buyers increasingly ask for this evidence at procurement, not after go-live.

How DigiSafe helps

We help AI and AVT vendors build assurance into the product, not bolt it on. From safety case to monitoring dashboards to incident playbooks, the work that turns a clever model into a clinically deployable one.

Want this applied to your product?

We turn standards like this into evidence packs, safety cases and embedded CSO support, so you can focus on building.